Antacids Market Size, Share, Growth, Trends with Impact of Covid-19 and Forecast by 2022-2030
SKU ID : INH-18092844 | Publishing Date : 26-Apr-2021 | No. of pages : 100
Antacids Market Report is projected to grow at a CAGR of XX% during the forecast period 2021-2024.
Company Coverage: -
- AstraZeneca PLC
- Bayer AG
- Boehringer Ingelheim GmbH
- Dr. Reddy's Laboratories Ltd
- GlaxoSmithKline PLC
- Johnson & Johnson
- Pfizer Inc.
- Procter & Gamble
- Reckitt Benckiser Group PLC
- Sanofi S.A
Scope: -
As per the , antacids are a widely available medication used for slowing heartburn, sore stomach, acid indigestion, and stomach upset. It is helpful in protecting the stomach, duodenum, and esophagus from harsh acids released while eating foods. The antacids generally do not require a prescription, in other words, they are self-prescribed. Therefore, they provide quick relief from heartburn, which is a major symptom of gastroesophageal reflux disease and indigestion.
Regions: -
- North America
- Asia-Pacific
- Europe
- South America
- Africa
Key Highlights of Report:
- Provides market definition and overview by studying objectives like market scope and market size estimation.
- Provides research methods and logic based on historic data.
- Analysis market competition, market performance worldwide, manufactures basic information, Sales, Value, Price and Gross Margin.
- Analysis on segmentation of types, applications and regions based on historical Data and market forecasts.
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region